OTSUKA CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,105 JPY | +0.16% |
|
+0.06% | +6.83% |
| Apr. 09 | H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy | MT |
| Mar. 29 | Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
OTSUKA CORPORATION is a Japan-based company mainly engaged in the sale of system equipment, the installation support and maintenance services. The Company operates through two business segments. System Integration segment conducts consulting, hardware and software sales, contract software development, equipment installation and network construction. Service & Support segment provides office supply, maintenance services, as well as business support services. The Company is also involved in the car maintenance business and insurance business.
Sector
IT Services & Consulting
Calendar
2024-04-29
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
3,105
JPY
Average target price
3,591
JPY
Spread / Average Target
+15.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.83% | 7.48B | |
| -7.42% | 31.57B | |
| +0.21% | 15.14B | |
| -6.71% | 8.91B | |
| +3.85% | 4.94B | |
| -45.75% | 4.44B | |
| +12.35% | 2.99B | |
| +8.53% | 2.44B | |
| -13.45% | 2.36B | |
| -15.17% | 2.06B |
- Stock Market
- Equities
- 4768 Stock
- News Otsuka Corporation
- Aurinia Pharmaceuticals Partner Otsuka Pharmaceutical Files New Drug Application For Voclosporin in Japan
